SCHEMBL29408192

SCHEMBL29408192

Cc1cc(C(=O)O)cc(-c2ccc(OC(F)F)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 2/20 0.48
MCL1 Q07820 3/20 0.47
SCN9A Q15858 3/20 0.44
PTGER4 P35408 1/20 0.44
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
PTPN7 P35236 1/20 0.43
RECQL P46063 1/20 0.43
DUSP3 P51452 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
HPGD P15428 1/20 0.42
GRM2 Q14416 1/20 0.42
MIF P14174 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658051 1.00 CTRC (0.48) CTRCMCL1SCN9APTGER4KDM4E
SCHEMBL29408125 0.87 SCN9A (0.45) CTRCSCN9AKDM4EMAPK1MEN1
SCHEMBL22658101 0.87 SCN9A (0.45) CTRCSCN9AKDM4EMAPK1MEN1
SCHEMBL14919880 0.81 SCN9A (0.64) MCL1SCN9A
SCHEMBL22678577 0.80 NPSR1 (0.45) MCL1KDM4EMAPK1MEN1POLB
SCHEMBL16706636 0.79 CTRC (0.66) CTRCMCL1KDM4EMEN1KMT2A
SCHEMBL22678524 0.78 MCL1 (0.47) MCL1SCN9APTGER4MRGPRX4GRM2
SCHEMBL29408290 0.78 MCL1 (0.47) MCL1SCN9APTGER4MRGPRX4GRM2
SCHEMBL20346112 0.78 CTRC (0.61) CTRCMCL1PTGER4KDM4EMEN1
SCHEMBL16710006 0.76 ADORA3 (0.52) CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969439-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-03-23 EP disclosed
CN-114127049-A ACSS2 inhibitors and methods of use thereof 美特波米德有限公司 2022-03-01 CN disclosed